山东绿叶制药有限公司 Lvye
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao 2024-03-07 10:11
Luye Pharma Grants Myung In Pharm Exclusive Rights to Commercialize Rivastigmine Twice Weekly Transdermal Patch in South Korea 2024-02-05 18:53
Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia 2023-04-05 10:44
Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong 2023-01-09 18:57
Luye Pharma and DCH Auriga Establish an Exclusive Distribution Partnership and Jointly Launch the "We Care About Mental Health" Initiative 2022-12-13 12:14
Luye Pharma Enters Local Seroquel® Distribution and Marketing Partnership with ICI Pakistan Limited 2022-09-27 07:59
Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therapeutics 2021-06-24 14:49
Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China 2021-05-26 23:03
Luye Pharma and Distriphil Enter Exclusive Distribution Partnership in the Philippines with Joint Commitment to Raising Mental Health Awareness 2020-11-26 16:44
Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR® 2020-06-01 15:22
The First Asia Pacific Psychiatry Symposium Takes Place 2019-09-03 13:11
The First Asia Pacific Psychiatry Symposium Takes Place 2019-09-03 12:44
1